ALDOSTERONE SYNTHASE INHIBITION WITH OR WITHOUT BACKGROUND SODIUM GLUCOSE COTRANSPORTER 2 INHIBITION IN CKD: A PHASE II CLINICAL TRIAL

https://storage.unitedwebnetwork.com/files/1099/c5ee389920d675b1fcf1403a005bdac3.pdf
ALDOSTERONE SYNTHASE INHIBITION WITH OR WITHOUT BACKGROUND SODIUM GLUCOSE COTRANSPORTER 2 INHIBITION IN CKD: A PHASE II CLINICAL TRIAL
Katherine
Tuttle
Sibylle Hauske sibylle.hauske@boehringer-ingelheim.com Boehringer Ingelheim International GmbH CMR Medicine Ingelheim am Rhein Vth Department of Medicine, University Medical Center Mannheim, Heidelberg University
Shimoli V Shah shimoli.shah@boehringer-ingelheim.com Boehringer Ingelheim Pharmaceuticals Inc. Global Patient Safety & Pharmacovigilance Ridgefield
Lisa Cronin lisa.cronin@boehringer-ingelheim.com Boehringer Ingelheim Pharmaceuticals Inc. CardioMetabolism & Respiratory Medicine Ridgefield
Zhichao Sun zhichao.sun@boehringer-ingelheim.com Boehringer Ingelheim Pharmaceuticals Inc. Global Biostatistics & Data Sciences Ridgefield
Dick de Zeeuw ZeeuwDrugAdvice@outlook.com University Medical Center Groningen Department of Clinical Pharmacy and Pharmacology Groningen
Hiddo J L Heerspink h.j.lambers.heerspink@umcg.nl University Medical Center Groningen Department of Clinical Pharmacy and Pharmacology Groningen
Peter Rossing peter.rossing@regionh.dk Steno Diabetes Center Copenhagen Complications Research Copenhagen
 
 
 
 
 
 
 
 
E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos